Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate Ubiquitination-Reference-Cited by-同舟云学术

Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate Ubiquitination

Published:2022-01-06 Issue:2 Volume:17 Page:449-462
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Chen Hao¹²,Wu Yuntong¹²,Li Kunlun¹²,Currie Iain¹²,Keating Narelle¹²,Dehkhoda Farhad¹²,Grohmann Christoph¹²,Babon Jeffrey J.¹²,Nicholson Sandra E.¹²,Sleebs Brad E.¹²^ORCID

Affiliation:

1. The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia

2. Department of Medical Biology, The University of Melbourne, Parkville 3010, Australia

Funder

Department of Health, State Government of Victoria

National Health and Medical Research Council

Australian Cancer Research Foundation

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.1c00884

Reference45 articles.

1. A Directed Protein Interaction Network for Investigating Intracellular Signal Transduction

2. The molecular details of cytokine signaling via the JAK/STAT pathway

3. Signaling through the JAK/STAT pathway, recent advances and future challenges

4. Biology and significance of the JAK/STAT signalling pathways

5. SOCS Proteins: Negative Regulators of Cytokine Signaling

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the pathological functions of SOCS in colorectal cancer: Current concepts and future perspectives;Pathology - Research and Practice;2024-10

2. Design and characterization of a heterobifunctional degrader of KEAP1;Redox Biology;2023-02

3. Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights;European Journal of Medicinal Chemistry;2022-12

4. Structure-Activity Relationship Investigations of Novel Constrained Chimeric Peptidomimetics of SOCS3 Protein Targeting JAK2;Pharmaceuticals;2022-04-09